SEC Form 4 · accession 0001209191-17-028533
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Duggan
10% Owner
Period of report
Apr 25, 2017
Accepted (ET)
Apr 27, 2017 · 9:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 25, 2017 | P | 25,187 | $24.938 | A | 2,923,379 | D | |
| Common StockF2 | Apr 26, 2017 | P | 10,000 | $24.469 | A | 2,933,379 | D | |
| Common Stock | Apr 27, 2017 | P | 200 | $22.95 | A | 2,933,579 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is the weighted average purchase price of the shares, which ranged from $24.841 to $24.978 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F2This is the weighted average purchase price of the shares, which ranged from $24.45 to $24.47 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.